Sparian Biosciences Inc. has been awarded a $19.5 million, 5-year grant to fund development of SBS-226 from IND submission through phase I development. SBS-226 is a first-in-class dual μ-opioid ...
Brain volume and function are altered in individuals with opioid use disorder, a new Yale study finds. Using magnetic resonance imaging (MRI) and functional MRI (fMRI), researchers observed the ...
Access to medications for opioid use disorder (OUD) in the pharmacy is internationally accepted; however, in the US, methadone treatment for OUD can only be provided by opioid treatment programs (OTPs ...
Zhanette Coffee, Ph.D., MSN, APRN, spent years working as an advanced practice nurse with certifications in family practice and addictions nursing and saw firsthand the challenges faced not only by ...
The use of medication for opioid use disorder (MOUD) in older adults has increased over the years, yet disparities persist across patient subgroups, with men, Black and Hispanic individuals, rural ...
Integrating OUD treatment into CCM in primary care significantly reduces opioid use compared to usual care, with sharper declines observed in the intervention group. The study found modest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results